Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 8

SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin

Total article views   HTML views PDF downloads Totals
20,078 Dovepress* 15,121+ 2,380 17,501
PubMed Central* 4,957 1,420 6,377
Totals 20,078 3,800 23,878
*Since 9 November 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar